Compared with the normal controls, the expression levels of FDX1, LIPT1, PDHB, GLS, and CDKN2A were upregulated, whereas the expression levels of NLRP3, ATP7B, ATP7A, DLD, PDHA1, MTF1, and DLST were downregulated in the MM samples. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.